.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Accenture
Deloitte
Merck
McKinsey
Daiichi Sankyo
QuintilesIMS
Dow
Cipla
UBS

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019672

« Back to Dashboard
NDA 019672 describes EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE, which is a drug marketed by Alza and is included in one NDA. Additional details are available on the EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE profile page.

The generic ingredient in EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE is brompheniramine maleate; pseudoephedrine hydrochloride. There are twenty-one drug master file entries for this compound. Additional details are available on the brompheniramine maleate; pseudoephedrine hydrochloride profile page.

Summary for NDA: 019672

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrength16MG;240MG
Approval Date:Mar 29, 1996TE:RLD:No

Expired Orange Book Patents for NDA: 019672

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alza
EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE
brompheniramine maleate; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL019672-001Mar 29, 19964,810,502► Subscribe
Alza
EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE
brompheniramine maleate; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL019672-001Mar 29, 19964,662,880► Subscribe
Alza
EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE
brompheniramine maleate; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL019672-001Mar 29, 19964,801,461► Subscribe
Alza
EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE
brompheniramine maleate; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL019672-001Mar 29, 19964,673,405► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Citi
Moodys
Healthtrust
Accenture
Johnson and Johnson
Harvard Business School
US Department of Justice
Federal Trade Commission
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot